Aerin Medical Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 74
Employees
  • Latest Deal Type
  • Series E
  • Latest Deal Amount
  • $48M
Latest Deal Amount
  • Investors
  • 9

Aerin Medical General Information

Description

Developer of non-invasive treatment device designed to improve symptoms of nasal breathing disorders. The company's device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion, enabling patients suffering from nasal breathing disorders to open their nasal airway safely and effectively.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Therapeutic Devices
Primary Office
  • 232 East Caribbean Drive
  • Sunnyvale, CA 94089
  • United States
+1 (678) 000-0000

Aerin Medical Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aerin Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series E) 17-Aug-2020 $48M 00000 00000 Completed Generating Revenue
7. Debt Refinancing 22-May-2019 0000 000.00 Completed Generating Revenue
6. Later Stage VC (Series D) 19-Dec-2017 0000 000.00 0000 Completed Generating Revenue
5. Mezzanine 13-Dec-2017 0000 000.00 Completed Startup
4. Later Stage VC (Series C) 21-Mar-2016 000.00 000.00 000.00 Completed Startup
3. Later Stage VC (Series C) 13-Feb-2014 00000 00000 00.000 Completed Startup
2. Early Stage VC (Series B) 12-Oct-2012 $125K $250K 00.000 Completed Startup
1. Early Stage VC (Series A) 12-Dec-2011 $125K $125K 00.000 Completed Startup
To view Aerin Medical’s complete valuation and funding history, request access »

Aerin Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.0 00.000
Series B 646,763 $0.001000 $0.06 $0.77 $0.77 1x $0.49 0.59%
Series A 1,010,560 $0.001000 $0.05 $0.57 $0.57 1x $0.4 0.83%
To view Aerin Medical’s complete cap table history, request access »

Aerin Medical Executive Team (8)

Name Title Board Seat Contact Info
Matt Brokaw Chief Executive Officer & President
Fred Dinger III Chief Operating Officer, Chief Executive Officer & Board Member
William McClellan Jr. Chief Financial Officer
Andrew Frazier Vice President, Engineering and Manufacturing Operations & Co-Founder
Scott Miller Vice President, Finance and Operations
You’re viewing 5 of 8 executive team members. Get the full list »

Aerin Medical Board Members (12)

Name Representing Role Since
David Thrower Aerin Medical Board Member 000 0000
Karen Long KCK Group Chairman 000 0000
Kern Bhugra Self Board Member 000 0000
Ryan Drant Self Board Member 000 0000
Scott Wolf MD Aerin Medical Co-Founder, Chief Medical Officer, Board Member & President 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Aerin Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aerin Medical Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
OrbiMed PE/Buyout Minority 000 0000 000000 0
Questa Capital Venture Capital Minority 000 0000 000000 0
Barshop Ventures Family Office Minority 000 0000 000000 0
David Shen Ventures Venture Capital Minority 000 0000 000000 0
Horizon Technology Finance Lender/Debt Provider Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »